tirzepatide vs semaglutide potency versus Once Weekly in Patients with Type 2 Diabetes Tirzepatide vs semaglutide dosage chart:

In September 2024, the FTC filed suit against the three major PBM companies CVS Caremark, Express Scripts, and OptumRx along with their affiliated group purchasing organizations, alleging that their practices had artificially inflated insulin prices by favoring high-list-price insulins on formulary to maximize rebate revenue

In fact, some preliminary research suggests GLP-1 agonists may have modest anti-inflammatory properties (Lee & Jun, 2016, Endocrinology and Metabolism )

I love this as science, but like, as far as sitting at a desk drilling oil wells for the next 50 years, this is not going to be for me

Thanks for bringing it up